Materials and methods
All chemicals and reagents were purchased from commercial suppliers and were used without further purification, unless otherwise noted. In all experiments, MilliQ standard water (Millipore Inc., USA) with a typical resistivity of 18.2 MΩ/cm was used. Lipid-DNAs were purified by reversed-phase high performance liquid chromatography (RP-HPLC) using a C15 RESOURCE RPCTM 1 ml reverse phase column (GE Healthcare) through custom gradients using elution buffers (A: 100 mM triethylammonium acetate (TEAAc) and 2.5% acetonitrile (ACN), B: 100 mM TEAAc and 65% ACN). Afterwards the lipid-DNAs were characterized by MALDI-TOF mass spectrometry using a 3-hydroxypicolinic acid matrix. Spectra were recorded on an ABI
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Voyager DE-PRO MALDI-TOF (delayed extraction reflector) Biospectrometry
Workstation mass spectrometer. The concentrations of the DNA were determined on a Jasco V-630 spectrophotometer (Jasco Benelux B.V., Netherlands) using 1 cm light-path quartz cuvette. Pristine DNAs were purchased from Biomers.net at HPLC purification grade. Absorption spectra were recorded on a Specord S 600 (Analytic Jena) spectrometer.
A 0.1 x 1 cm cuvette was used for solubilizer-screening experiments and 1 x 1 cm cuvette for other measurements. The loading concentrations of mTHPC were determined by RP-HPLC using Xterra Prep MS C18, 10 µm, 7.8 x 150 mm column (Waters) through custom gradients using elution buffers (A: H 
Synthesis and characterization of lipid-DNAs
The modified 5-(dodec-1-ynyl)uracil phosphoramidite 2 was synthesized in two steps as previously reported starting from 1 (Scheme S1). [1] Subsequently, the modified uracil phosphoramidite was dissolved in ACN to adjust the concentration to 0.15 M and directly connected to the DNA synthesizer. All oligonucleotides were synthesized on a 50 µmol scale on an ÄKTA oligopilot plus (GE Healthcare) DNA synthesizer using standard β-cyanoethylphosphoramidite coupling chemistry. Deprotection and cleavage from the PS support was carried out by incubation in concentrated aqueous ammonium hydroxide 4 solution at 55 °C for 5 h. Following this step, the oligonucleotides were purified by using RP-HPLC, using a C15 RESOURCE RPC TM 1 mL reversed phase column (GE Healthcare) through custom gradient elution (A: 100 mM TEAAc and 2.5% ACN, B: 100 mM TEAAc and 65% ACN). Fractions were desalted using centrifugal dialysis membranes (MWCO 3000, Sartorius Stedim) or a HiTrap Desalting column (GE Healthcare). DNA concentrations were determined by UV absorbance using their respective extinction coefficients. The purity was characterized by RP-HPLC ( Figure S1 ) on a Shimadzu VP series HPLC system with PDA detector using a C4 Jupiter 5 µm 300 Å 1 mL reversed phase column (Phenomenex) through custom gradient elution (A: 100 mM TEAAc and 5% ACN, B: Methanol). Finally, the identity of the oligonucleotides was confirmed by MALDI-TOF mass spectrometry ( Figure S2 ). UUUUUU12mer (calc. 4534 g/mol, found 4527 g/mol).
6

Pretreatment of DNA aqueous solutions
Single-stranded DNAs (11mer, c11mer, 12mer, UU11mer, UUUUUU12mer, 50 µM), dsUU11mer (UU11mer 50 µM, c11mer 50 µM, MgCl 2 10 mM) and ds11mer (11mer 50 µM, c11mer 50 µM, MgCl 2 10 mM) were thermally cycled (90 °C, 30 min; -1 °C/2 min until room temperature) by using a polymerase chain reaction (PCR) thermocycler (Biorad, USA) before use.
Critical micelle concentration (CMC) determination
For CMC determination, firstly 10 pmol of 1,6-diphenyl-1,3,5-hexatriene (DPH) was loaded in Eppendorf DNA low-binding tubes using a solution in acetone (1 µM). The solvent was allowed to evaporate at room temperature for 5 h after which DNA amphiphile solution (100 µL) was added. The oligonucleotides were prepared at concentrations ranging from 0.0025 to 1 g/L in 1x TAE buffer (10 mM Tris Acetate, 0.2 mM EDTA, 20 mM NaCl, 12 mM MgCl 2 , pH 8.0) and thermally cycled before use. After addition to the DPH-containing tubes, the solutions were shaken at 37 °C overnight.
Subsequently, fluorescence spectra (375-500 nm) were recorded on a Varian Cary Eclipse fluorometer (Varian Nederland B.V.) at room temperature using an excitation wavelength of 350 nm. For the CMC analysis, the intensity at 425 nm (maximum) was plotted against the logarithm of the lipid-DNA concentration ( Figure S3 ). The CMCs were determined to be 29 and 24 µM for UU11mer and UUUUUU12mer, respectively. 
Cryogenic electron microscopy (Cryo-EM)
Cyro-EM was performed according to a standard procedure. A sample suspension (3 µL)
was placed on a glow-discharged holy carbon coated grid (Quantifiol 3.5/1) blotted and vitrified in a Vitrobot (FEI). Samples were observed in a Gatan 626 cryo-stage in a
Philips CM120 operating at 120 keV or in a FEI Tecnai T20 operating at 200 keV. Images were recorded under low-dose conditions on a slow-scan CCD camera. Table S1 . Diameters of lipid-DNA micelles before and after mTHPC loading obtained through cryo-EM.
Sample UU11mer
Diameter (nm) 9.8 ± 1.0 11.1 ± 1.7 9.9 ± 2.0 11.4 ± 1.6 8.2 ± 1.8 9.0 ± 2.0 (-) Without mTHPC; (+) Loaded with mTHPC.
Dynamic Light Scattering (DLS)
The measurements used a 3D DLS spectrometer (LS Instruments, Fribourg, Switzerland) equipped with a 25mW HeNe laser (JDS uniphase) operating at l=632.8 nm, a two channel multiple tau correlator (1088 channels in autocorrelation), a variable-angle detection system, and a temperature-controlled index matching vat (LS Instruments). The scattering spectrum was measured using two single mode fibre detections and two high sensitivity APD detectors (Perkin Elmer, model SPCM-AQR-13-FC).
Fluctuations in the scattered intensity with time I(q,t) (also called count rate), measured at a given scattering angle q or equivalently at a given scattering wave vector 
Setup for singlet oxygen ( 1 O 2 ) generation experiments
A 1 x 1 cm cuvette was used for the measurements. Near-infrared emission spectra were recorded using an Andor iDus InGaAs detector coupled with a Shamrock 163 spectrograph with excitation using a 4 mW 405 nm diode laser (Thorlabs LDM 405).
Tris(bipyridine)ruthenium(II) chloride (Ru(bpy) 3 Cl 2 ) was used as reference sensitizer.
Preparation of samples for solubilizer-screening experiment
First, mTHPC (340 µg, 0.5 µmol) in ethanol (1 mg/mL) was loaded into a vial and the solvent was removed under vacumn at 30 °C for 3 h. The pretreated DNA aqueous solution (500 µL) was added directly to mTHPC, and the mixture was stirred (1000 r/min) at 37 °C for 12 h. After centrifugation (10000 r/min) for 15 min, the supernatant loaded with mTHPC was obtained without touching the pellet. Aluminum foil was used to cover Preparation of maximum mTHPC-loaded lipid-DNA micelles mTHPC (680 µg, 1 µmol) in ethanol (1 mg/mL) was mixed with pretreated aqueous DNA solution (1000 µL) and stirred (1000 r/min) at room temperature for 1 h. After that, the mixture was lyophilized, and H 2 O (1000 µL) was added. The mixture was stirred (1000 r/min) at room temperature for 1 h. After centrifugation (10000 r/min) for 15 min, the supernatant loaded with mTHPC was obtained without touching the pellet. Aluminum foil was used to cover the samples to avoid photochemical degradation of mTHPC throughout the experiments.
Preparation of samples for 1 O 2 -generation experiment
mTHPC 680 µg (1 µmol) in ethanol (1 mg/mL) was loaded into a vial, the solvent was removed under vacuum at 30 °C for 5 h. In the meantime, the aqueous solution of UU11mer (50 µM in D 2 O, 4000 µL) and dsUU11mer (UU11mer 50 µM, c11mer 50 µM, MgCl 2 10 mM in D 2 O, 4000 µL) was prepared and thermally cycled as described above.
After that, the solutions obtained were added directly to mTHPC, and the mixtures were stirred (1000 r/min) at room temperature for 6 h. After centrifugation (10000 r/min) for 15 min, the supernatants were obtained without touching the pellet. Aluminum foil was used to cover the sample to avoid photochemical degradation of mTHPC throughout the experiments.
Determination of mTHPC loading concentrations and loading capacities
To determine the loading capacities, the isolated supernatant (400 µL) was lyophilized,
followed by the addition of cold ethanol (400 µL) to extract mTHPC. After centrifugation (10000 r/min) for 15 min, the supernatant was removed to determine the drug loading concentration and loading capacity through RP-HPLC measurement. Loading capacities were calculated by using equation S1:
Preparation of the stock solution of mTHPC (2 mM) loaded UU11mer micelles UU11mer (1.7 mM, 4 mL) in MiliQ H 2 O was thermally cycled (90 °C, 30 min; -1 °C/2 min until RT) by using a polymerase chain reaction (PCR) thermocycler (Biorad, USA) before use. Then it was diluted to 800 µM (8.5 mL) with MiliQ H 2 O. mTHPC (6.8 mg)
was dissolved in ethanol (6.8 mL), and it was mixed with pretreated aqueous DNA solution (8.5 mL) and stirred (1000 r/min) at room temperature for 1 h. After that, the mixture was lyophilized, and H 2 O (2 mL) was added. The mixture was stirred (1000 r/min) at room temperature for 1 h. After centrifugation (10000 r/min) for 15 min, the solution A was obtained. Aluminum foil was used to cover the samples to avoid photochemical degradation of mTHPC throughout the experiments.
To determine the loading concentration of solution A, the isolated supernatant (20 µL) was lyophilized, followed by the addition of cold ethanol (1360 µL) to extract mTHPC.
After centrifugation (10000 r/min) for 15 min, the supernatant was removed and diluted five times for RP-HPLC measurement to determine and calculate the drug loading concentration of solution A. The drug loading concentration of solution A was found to be 7045 µM. Finally, solution A was diluted with MiliQ water to obtain the stock solution.
In vitro phototoxcity of mTHPC loaded UU11mer
Human epidermoid carcinoma A253, human epithelial carcinoma A431, human oral adenosquamous carcinoma CAL27, murine hematopoiesis monocytic macrophages 
